MELISSA PARKS: Open Payments
NPI 1114277324 · DALTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,709 in 138 payments from 33 companies in 2025. Trend: 2023 $1,922 · 2024 $3,279 · 2025 $2,709
Food & beverage: $2,699Education: $9
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $427 |
| UCB, Inc. | 18 | $356 |
| Amneal Pharmaceuticals LLC | 12 | $214 |
| Biogen, Inc. | 9 | $197 |
| ACADIA Pharmaceuticals Inc | 11 | $159 |
| JAZZ PHARMACEUTICALS INC. | 5 | $98 |
| ARGENX US, INC. | 4 | $92 |
| SK Life Science, Inc. | 3 | $90 |
| Aucta Pharmaceuticals, Inc. | 4 | $85 |
| Neurocrine BioSciences, Inc. | 3 | $76 |
Products named: CREXONT, QULIPTA, TYSABRI, NUPLAZID, BOTOX, Rystiggo, Fintepla, VYVGART HYTRULO.
Industry payments across GA — which companies pay providers there.
